Cellular Origins and Fresenius Kabi have completed the first phase of a CGT manufacturing collaboration announced in October ...
Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.
CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...
Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...
Private networks transitioning from connectivity platforms to intelligent automation infrastructure across manufacturing, healthcare, ports, and beyond.
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results